Apotex Inc. has voluntarily recalled over 1.8 million bottles of various ranitidine hydrochloride tablets, including store brands for Walgreens, Walmart (Equate), and Rite Aid. These products, commonly used as acid reducers for heartburn relief, were manufactured with potential deviations from good manufacturing practices. Specifically, there is a risk that the tablets contain an impurity called N-nitrosodimethylamine (NDMA). No injuries or adverse events have been reported to date for these products, which were distributed nationwide in the United States.
The tablets may contain N-nitrosodimethylamine (NDMA), which is classified as a probable human carcinogen. Long-term exposure to levels of NDMA above acceptable limits could potentially increase the risk of cancer.
Full refund upon return
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.